Yearly Archives: 2012

The U.S. Food and Drug Administration today approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.

Biologists at UC San Diego have discovered a chemical that offers a completely new and promising direction for the development of drugs to treat metabolic disorders such as type 2 diabetes.

Women with diabetes are just as likely to be interested in, and engage in, sexual activity as non-diabetic women, but they are much more likely to report low overall sexual satisfaction.

Researchers have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy.

Despite the increasing awareness of the problem of obesity in the United States, most Americans don't know whether they are gaining or losing weight.

Scientists have used injections of antibodies to rapidly reverse the onset of Type I diabetes.

The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action.

People with Type 2 diabetes are usually advised to keep a low-fat diet. Now, a study shows that food with a lot of fat and few carbohydrates could have a better effect on blood sugar levels and blood lipids.

After people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. Now researchers have identified the misstep that sparks this runaway chronic damage and a promising way to block it.

A new variety of long-lasting insulin lowers the risk of nighttime low blood sugar in elderly diabetic adults compared with insulin glargine.

A new study presents more evidence of a possible link between low vitamin D levels and a higher risk of Type 2 diabetes and heart disease.

Researchers are encouraging primary care physicians to screen for obstructive sleep apnea in patients with Type 2 diabetes. They found that the risk for sleep apnea was higher among diabetics compared with non-diabetics, and that sleep apnea seemed to be associated with carbohydrate craving.

Why diabetics suffer from increased pain and temperature sensitivity is a step closer to being understood and effectively treated.

New research points to the naturally produced protein apolipoprotein A-IV as a potential target for a new diabetes therapeutic.

Obese people who consume increased amounts of fructose, a type of sugar that is found in particular in soft drinks and fruit juices, are at risk for nonalcoholic fatty liver disease (NFALD) and more its more severe forms, fatty inflammation and scarring.

Middle-aged and older adults with diabetes showed substantial survival rates in a new study of retirees.